PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b

Biochemical and Biophysical Research Communications

Volumn 462, Issue 2, 2015, Pages 85-90

  Luo, Shuang ^a   Wang, Jidong ^b   Ma, Ying ^a   Yao, Zhenwei ^c   Pan, Hongjuan ^d  

^a SUINING CENTRAL HOSPITAL   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

miR 125b; Ovarian cancer; PPAR ; Proliferation

Indexed keywords

ANTAGOMIR; CIGLITAZONE; LIGAND; LUCIFERASE; MICRORNA 125B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN BCL 3; TROGLITAZONE; MICRORNA; MIRN125 MICRORNA, HUMAN; ONCOPROTEIN; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN BCL-3; TRANSCRIPTION FACTOR;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG BINDING SITE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; RNA BINDING; UPREGULATION; ANTAGONISTS AND INHIBITORS; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; PROTO ONCOGENE; REGULATORY SEQUENCE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84929838506     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.04.023     Document Type: Article

References (36)

1. R. Schickel, B. Boyerinas, S.M. Park, and M.E. Peter MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death Oncogene 27 2008 5959 5974
2. W. Filipowicz, S.N. Bhattacharyya, and N. Sonenberg Mechanisms of post- transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9 2008 102 114
3. L. He, and G.J. Hannon MicroRNAs: small RNAs with a big role in gene regulation Nat. Rev. Genet. 5 2004 522 531
4. J. Banzhaf-Strathmann, and D. Edbauer Good guy or bad guy: the opposing roles of microRNA 125b in cancer Cell. Commun. Signal 12 2014 30
5. E.L. McKinsey, J.K. Parrish, A.E. Irwin, B.F. Niemeyer, H.B. Kern, D.K. Birks, and P. Jedlicka A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs Oncogene 30 2011 4910 4920
6. J. Li, T. You, and J. Jing MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway Cell. Prolif. 47 2014 152 160
7. H. Nakanishi, C. Taccioli, J. Palatini, C. Fernandez-Cymering, R. Cui, T. Kim, S. Volinia, and C.M. Croce Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway Oncogene 33 2014 702 712
8. Y. Guan, H. Yao, Z. Zheng, G. Qiu, and K. Sun MiR-125b targets BCL3 and suppresses ovarian cancer proliferation Int. J. Cancer 128 2011 2274 2283
9. J. He, Y. Jing, W. Li, X. Qian, Q. Xu, F.S. Li, L.Z. Liu, B.H. Jiang, and Y. Jiang Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis PLoS One 8 2013 e56647
10. Y.M. Sun, K.Y. Lin, and Y.Q. Chen Diverse functions of miR-125 family in different cell contexts J. Hematol. Oncol. 6 2013 6
11. K. Huang, S. Dong, W. Li, and Z. Xie The expression and regulation of microRNA-125b in cancers Acta. Biochim. Biophys. Sin. (Shanghai) 45 2013 803 805
12. E. Tili, J.J. Michaille, and C.M. Croce MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer Immunol. Rev. 253 2013 167 184
13. K.Y. Lin, X.J. Zhang, D.D. Feng, H. Zhang, C.W. Zeng, B.W. Han, A.D. Zhou, L.H. Qu, L. Xu, and Y.Q. Chen miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies J. Biol. Chem. 286 2011 38253 38263
14. L.H. Liu, H. Li, J.P. Li, H. Zhong, H.C. Zhang, J. Chen, and T. Xiao miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3 Biochem. Biophys. Res. Commun. 416 2011 31 38
15. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
16. K.L. Houseknecht, B.M. Cole, and P.J. Steele Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review Domest. Anim. Endocrinol. 22 2002 1 23
17. J.D. Burton, D.M. Goldenberg, and R.D. Blumenthal Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types PPAR Res. 2008 2008 494161
18. C. Grommes, G.E. Landreth, and M.T. Heneka Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists Lancet Oncol. 5 2004 419 429
19. G.Y. Zhang, N. Ahmed, C. Riley, K. Oliva, G. Barker, M.A. Quinn, and G.E. Rice Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma Br. J. Cancer 92 2005 113 119
20. B. Davidson, R. Hadar, H.T. Stavnes, C.G. Trope, and R. Reich Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival Hum. Pathol. 40 2009 705 713
21. S. Kim, J.J. Lee, and D.S. Heo PPARgamma ligands induce growth inhibition and apoptosis through p63 and p73 in human ovarian cancer cells Biochem. Biophys. Res. Commun. 406 2011 389 395
22. C.J. Brown, S. Lain, C.S. Verma, A.R. Fersht, and D.P. Lane Awakening guardian angels: drugging the p53 pathway Nat. Rev. Cancer 9 2009 862 873
23. T.O. Akinyeke, and L.V. Stewart Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARgamma-independent mechanism Cancer Biol. Ther. 11 2011 1046 1058
24. H.K. Na, and Y.J. Surh Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation Biochem. Pharmacol. 66 2003 1381 1391
25. S.L. Maines-Bandiera, P.A. Kruk, and N. Auersperg Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix Am. J. Obstet. Gynecol. 167 1992 729 735
26. B. Xie, Q. Ding, H. Han, and D. Wu miRCancer: a microRNA-cancer association database constructed by text mining on literature Bioinformatics 29 2013 638 644
27. M. Bousquet, C. Quelen, R. Rosati, V. Mansat-De Mas, R. La Starza, C. Bastard, E. Lippert, P. Talmant, M. Lafage-Pochitaloff, D. Leroux, C. Gervais, F. Viguie, J.L. Lai, C. Terre, B. Beverlo, C. Sambani, A. Hagemeijer, P. Marynen, G. Delsol, N. Dastugue, C. Mecucci, and P. Brousset Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation J. Exp. Med. 205 2008 2499 2506
28. N. Nishida, T. Yokobori, K. Mimori, T. Sudo, F. Tanaka, K. Shibata, H. Ishii, Y. Doki, H. Kuwano, and M. Mori MicroRNA miR-125b is a prognostic marker in human colorectal cancer Int. J. Oncol. 38 2011 1437 1443
29. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.G. Liu, H. Alder, G.A. Calin, S. Menard, and C.M. Croce MicroRNA signatures in human ovarian cancer Cancer Res. 67 2007 8699 8707
30. J. Youssef, and M. Badr Peroxisome proliferator-activated receptors and cancer: challenges and opportunities Br. J. Pharmacol. 164 2011 68 82
31. T.M. Garcia-Bates, G.M. Lehmann, P.J. Simpson-Haidaris, S.H. Bernstein, P.J. Sime, and R.P. Phipps Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies PPAR Res. 2008 2008 834612
32. D. Bonofiglio, E. Cione, H. Qi, A. Pingitore, M. Perri, S. Catalano, D. Vizza, M.L. Panno, G. Genchi, S.A. Fuqua, and S. Ando Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells Am. J. Pathol. 175 2009 1270 1280
33. N. Yamakawa-Karakida, K. Sugita, T. Inukai, K. Goi, M. Nakamura, K. Uno, H. Sato, K. Kagami, N. Barker, and S. Nakazawa Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity Cell. Death Differ. 9 2002 513 526
34. J.J. Liu, R.W. Huang, D.J. Lin, J. Peng, X.Y. Wu, Q. Lin, X.L. Pan, Y.Q. Song, M.H. Zhang, M. Hou, and F. Chen Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro Ann. Oncol. 16 2005 455 459
35. J.J. Liu, P.Q. Liu, D.J. Lin, R.Z. Xiao, M. Huang, X.D. Li, Y. He, and R.W. Huang Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro Ann. Hematol. 86 2007 173 183
36. R. Massoumi, K. Chmielarska, K. Hennecke, A. Pfeifer, and R. Fassler Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling Cell 125 2006 665 677